Viewing Study NCT00329693


Ignite Creation Date: 2025-12-25 @ 1:13 AM
Ignite Modification Date: 2026-01-26 @ 5:49 PM
Study NCT ID: NCT00329693
Status: COMPLETED
Last Update Posted: 2011-05-19
First Post: 2006-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide
Sponsor: Ferring Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: FE999051 CS01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Clinical Development Support
Old Organization: Ferring Pharmaceuticals

Collaborators